Both in Pharmaceuticals
Edesa Biotech vs Seres Therapeutics
Over the past year EDSA returned +45.3% and MCRB returned −81.4%; their daily moves had a correlation of 0.04.
EDSA +45.3% MCRB −81.4%Growth of $1, one year, split-adjusted
| Metric | EDSA | MCRB |
|---|---|---|
| Price | $3.56 | $3.48 |
| Market cap | $34.3M | $35.0M |
| Today | −2.47% | −1.14% |
| 1 month | −22.9% | −31.9% |
| 6 months | −33.2% | −60.5% |
| Year to date | +150.7% | −76.6% |
| 1 year | +43.0% | −81.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | 622.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 18.6× |
| Net cash | $10.3M | $15.6M |
| Dividend yield | — | — |
| Volatility (60d) | 75.2% | 69.1% |
| Short % of float | 6.1% | 4.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).